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Abstract Domain deletion mutants of the matrix metaHopro- 
teinases consisting of the catalytic domain only contain two zinc 
atoms per molecule. One is essential for catalysis, while the other 
may fulfil a structural role. We have analysed the zinc contents 
of both the full-length and the truncated mutants of prostromely- 
sin-1 and progelatinase A and report that the second zinc atom 
is not present in the full-length form of the proenzymes. Thus it 
seems likely that the role proposed for this zinc atom in maintain- 
ing the structure of the enzyme catalytic domain is performed by 
the C-terminal domain in the full-length enzyme. 
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1. Introduction 
The matrix metalloproteinases areendopeptidases which re- 
quire zinc for catalytic activity. They are members of the family 
of enzymes termed the 'metzincins' [1] which have as a common 
feature the zinc-binding motif HExxHxxGxxH in their catalytic 
domains. The crystal structures of the catalytic domains of 
human neutrophil and fibroblast collagenases [2-5] and the 
NMR structure of the catalytic domain of human stromelysin-1 
[6] have recently been reported. In addition, the structures of 
several other members of the metzincin family including the 
crayfish enzyme astacin [7,8], adamalysin II from snake venom 
[9] and the 50 kDa metalloproteinase from Serratia marcescens 
[10] have been solved. Despite limited sequence identity these 
enzymes hare a common type of 3-D structure with an open- 
sandwich topology in which two ~-helices are packed against 
a twisted t-sheet. The more distantly-related thermolysin and 
other bacterial zinc metalloendopeptidases alsohave this type 
of 3D structure. The matrix metalloproteinases, however, ap- 
pear to be unique among the metalloendopeptidases in that 
they contain an additional zinc atom which is not part of the 
active centre and which appears to play a structural role in the 
enzymes. Both the catalytic and structural zinc atoms are very 
tightly bound in the proenzymes [11]. The catalytic zinc atom 
is coordinated by three histidine imidazole groups and a thiol 
group from the propeptide whereas the second zinc atom is 
coordinated by three histidine imidazole groups and an aspartic 
acid carboxylate. 
The matrix metalloproteinases possess domain structures. 
They all have a propeptide of approximately 80 amino acid 
residues which must be proteolytically removed in order to 
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form active enzyme. In addition, each matrix metallopro- 
teinase, with the exception of matrilysin, iscomprised of at least 
two domains, the N-terminal domain, which contains all the 
features essential for catalytic activity, and a C-terminal do- 
main, which is thought o be important in binding to physiolog- 
ical substrates and effectors. Truncated forms of the proen- 
zymes lacking the C-terminal domain have been constructed by 
using DNA technology and these are the forms that were used 
to determine the published structures. Some kinetic studies 
have been performed on these domain deletion mutants and 
they have been shown to have catalytic and specificity charac- 
teristics imilar to those of their full-length counterparts [12,13]. 
As part of a study designed to characterise more fully the 
full-length and short form enzymes, we have compared the zinc 
content of full-length prostromelysin-1 and progelatinase A 
with that of the truncated mutants, N-prostromelysin-1 and 
N-progelatinase A. Our results suggest that the C-terminal do- 
main may play an additional role in stabilising the structure of 
the catalytic domain. 
2. Materials and methods 
All reagents were purchased from BDH and were of Spectrosol or 
AristaR grade wherever possible. Prepacked PD-10 columns were from 
Pharmacia and Chelex-100 was from Bio-Rad. The substrate, 
(7-ethoxycoumarin-4-yl) acetyl-Pro-Leu-Gly-Leu-[3-(2,4-dinitrophen- 
yl)-L-2,3-diaminopropionyl]-Ala-Arg-NH2 was a generous gift from 
Dr. C.G. Knight (Strangeways Research Laboratory, Cambridge, 
UK). 
2.1. Enzyme preparation 
Recombinant human prostromelysin-I was purified from the me- 
dium of C 127 cells expressing this enzyme [14,15]. N-Prostromelysin- 1 
was prepared from transfected NSO mouse myeloma cell conditioned 
medium as previously described [16]. Progelatinase A and N-progelati- 
nase A were also expressed from NSO mouse myeloma cells and puri- 
fied from the conditioned media as described previously [17]. Pros- 
tromelysin-1 was expressed from NSO cells with low productivity and 
therefore could not be obtained in sufficient quantity to be used in the 
present study. However, a comparison of the stability, specific activity 
and activation kinetics of enzyme from the two cell lines confirmed that 
they have identical properties. The purity and latency of each proen- 
zyme was confirmed immediately before treatment for zinc analysis by 
using polyacrylamide g l electrophoresis (data not shown) in addition 
to a comparison of protein concentration a d active site titration data 
(see Results). 
2.2. Reagent preparation 
The buffer (50 mM HEPES, pH 7.5) was purified of contaminating 
metal ions by passage through acolumn of Chelex-100 (70 cm × 7 cm 2, 
flow rate 30 ml/h). Calcium nitrate ('Spectrosol' grade) from a stock of 
249 mM was added to give a final concentration f 2 mM Ca 2÷. The 
buffers were equilibrated to 4°C before use. When gel filtration was 
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used to purify the enzyme samples the columns were washed with 
o-phenanthroline followed by metal-free water and then equilibrated 
with the HEPES buffer at 4°C. Metal-free containers and dialysis 
tubing were prepared as described by Holmquist [18] and Auld [19]. 
2.3. Sample preparation 
Proenzyme samples were rendered free from non-specifically bound 
metal ions either by dialysis overnight or by gel filtration using pre- 
packed PD-10 columns. The concentration of the samples varied from 
0.5 7 pM. Acid hydrolysis was performed at 50°C in 20% nitric acid 
for 18 h. The zinc content of the buffers in which the samples were 
purified was used as a blank which was subtracted from the zinc con- 
centration of the enzyme. 
2.4. Zinc determination 
Zinc determination was performed using inductively coupled plasma 
mass spectroscopy (ICP-MS) at the National Environment Research 
Council's ICP-MS Facility in the Centre for Analytical Research in the 
Environment, Imperial College, Berkshire, UK. 
2.5. Determination of enzyme concentration 
Enzyme concentration was determined by titration of active enzyme 
with TIMP as described previously [20]. Prostromelysin-1 was activated 
by using 10 pg/ml trypsin for 30 min at 37°C and progelatinase A was 
activated by incubation with 2 mM (4-aminophenyl)mercuric acetate 
for 1 h at 25°C. Protein concentration was determined from the absorb- 
ance of the samples at 280 nm and using the extinction coefficients of 
the proenzymes: prostromelysin- 1 65,100 M-1 cm-J; N-prostromelysin- 
1 34,380 M -1. cm-I; N-progelatinase A 75,100 M -I. cm -t (all calculated 
from the amino acid sequences using method of Mach et al. [21]); 
progelatinase A 122,800 M -~. cm -1 (determined experimentally [22]). 
3. Results 
Initially, methods of sample preparation were compared by 
using full-length prostromelysin-1 to assess whether acid hy- 
drolysis was necessary to release of all the zinc from the protein 
and whether the proenzyme was denatured by either of the 
sample purification techniques. The results of the comparison, 
which are summarised in Table l, demonstrated that each of 
the treatments gave the same final zinc content for the proen- 
zyme. The dialysis treatment was used for the remaining sam- 
ples as the process had fewer steps and therefore fewer oppor- 
tunities for contamination by background zinc. The back- 
ground zinc concentrations were always less than 5% of the 
sample concentration. 
For  each proenzyme sample the protein, activated proen- 
zyme and zinc concentrations were determined. The compari- 
son between protein concentration and active enzyme concen- 
tration provided a method for ensuring: (a) that each prepara- 
tion was pure; and (b) that the proenzyme was fully activatable 
Table 1 
Effect of sample preparation method on the measured zinc content of 
stromelysin- 1 
Treatment [zinc] :[protein] [zinc] :[enzyme] 
+ S.D. (n = 2) + S.D. (n = 2) 
(1) Dialysis 0.93 + 0.07 0.9 + 0.08 
(2) Gel filtration 1.13 + 0.06 1.15 + 0.09 
(3) Acid hydrolysis 1.15 + 0.05 1.12 + 0.08 
Protein concentration was calculated from the A280 of the proenzymes, 
enzyme concentration was determined by active site titration of 
the active enzymes and zinc concentration of the proenymes was de- 
termined using ICP-MS. The instrumental nalytical precision was 
+ 1% at the lcr level. The values are the average of two separate deter- 
minations performed at different enzyme concentrations in the range 
0.5-7/./M. 
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Table 2 
The zinc contents of full-length and short-form stromelysin-1 and ge- 
latinase A 
Enzyme [zinc]: [protein] [zinc] :[enzyme] 
+ S.D. (n = 3) + S.D. (n = 3) 
Stromelysin-1 0.93 + 0.04 0.9 + 0.07 
N-Stromelysin-1 1.9 + 0.05 1.8 + 0.08 
Gelatinase A 1.0 + 0.08 1.1 + 0.18 
N-Gelatinase A 2.1 + 0.07 2.6 + 0.24 
Values are the average ratios obtained from three separate determina- 
tions. The larger errors for the [zinc] :[enzyme] ratio for gelatinase A 
and N-gelatinase A is a result of instability of the active nzyme during 
activation and titration. 
and therefore correctly folded. The latter is important because 
incorrectly folded proenzyme may have a different zinc content. 
The proenzymes were used for the zinc analysis to decrease the 
possibility of denaturation during dialysis in view of their 
known high conformational stability and tight binding of the 
catalytic zinc atom [1 1]. The activation conditions used have 
previously been demonstrated to give fully active enzyme 
[16,17]. 
Table 2 shows that for each enzyme there is a good correla- 
tion between the protein concentration calculated from meas- 
urements of  A280 and the concentration of active enzyme deter- 
mined by active site titration. Samples of each proenzyme 
which had not been dialysed were also activated and shown to 
contain concentrations of active enzyme similar to those of the 
dialysed samples, indicating that dialysis does not result in 
denaturation of the proenzyme and thus loss of zinc. 
The data in Table 2 demonstrate that there is an important 
difference in zinc stoichiometry between the full-length wild- 
type enzymes and the truncated mutants. Whereas the latter 
contain two zinc atoms per molecule, the former contain only 
one zinc atom per molecule. 
4. Discussion 
As part of a study of the consequences of replacing the zinc 
of matrix metalloproteinases by other metals, we determined 
the zinc content of prostromelysin-I to be one atom per mole- 
cule. The result of this preliminary experiment was surprising 
because published structures of the catalytic domains of 
stromelysin-1 and collagenase clearly contain two zinc atoms 
per molecule [2-6]. The activity of  trypsin-treated prostromely- 
sin-1 suggests that the single zinc atom performs a catalytic 
role. In the present work the validity of the analysis of one zinc 
atom per molecule suggested by the preliminary experiment on 
full-length prostromelysin-1 was confirmed by demonstrating 
the consistency of this result when different methods of sample 
preparation were used (Table 1). Evidence that the zinc con- 
tents of full-length matrix metalloproteinases differ from those 
of their short forms is provided by the analysis of the zinc 
contents of another full-length proenzyme, progelatinase A, 
and the domain deletion mutants of both proenzymes (Table 
2). 
Published values of zinc contents of the matrix metallopro- 
teinases are somewhat conflicting. The only other published 
value for a full-length proenzyme, also for prostromelysin-l, is 
1.5 atoms per molecule [1 1]. This result does not permit a 
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decision between 1 and 2 atoms per molecule. Promatrilysin, 
which is a naturally occurring 'short-form' enzyme, and the 
catalytic domain of fibroblast procollagenase have both been 
reported to contain 1 zinc atom per enzyme molecule [23,24]. 
These results, however, contrast with zinc contents of 2 atoms 
per molecule reported for the prostromelysin-1 catalytic do- 
main expressed in E. coli [11,25] and for pro- and active matri- 
lysin from both E. coli and mammalian cells [25]. The results 
of the present work shown in Table 2 demonstrate a real struc- 
turally relevant difference between the zinc contents of two 
full-length matrix metalloproteinases (1 atom per molecule of 
proenzyme) and their respective N-terminal short forms pro- 
duced by molecular genetic techniques (2 atoms per molecule 
of proenzyme). 
A structural role has been proposed for the second zinc atom 
on the basis of its position in the structure and its high affinity 
for the protein. The zinc atom is positioned approximately 12A. 
from the catalytic zinc atom and, together with a calcium ion, 
it holds a large exposed loop against the fl-sheet. It is surprising 
that the affinity of the zinc for the enzyme is so high because 
coordination by three histidine imidazoles and one aspartic 
acid carboxylate group has not been reported to be unusually 
strong in other proteins. Indeed, the zinc atom in superoxide 
dismutase, which is also coordinated to three histidines and one 
glutamic acid, can be removed readily [27]. An alternative ex- 
planation for the observation that the zinc atom cannot be 
removed from the domain is that it is inaccessible to chelating 
agents. This seems unlikely, however, as it is near the surface 
of the molecule. It is possible that the tight binding of this zinc 
atom may be due primarily to the nearby calcium atom which 
may maintain the conformation of the loop so effectively that 
the zinc is trapped in place. There is support for this possibility 
from a study of the roles of zinc and calcium in the stabilization 
of the conformation of the catalytic domain of human fibro- 
blast collagenase, where it was noted that calcium is signifi- 
cantly more effective at stabilizing the structure than is zinc [24]. 
The residues that coordinate the second zinc atom in the 
short form enzymes are totally conserved throughout the mem- 
bers of the matrix metalloproteinase family, suggesting that 
they and the zinc atom play a crucial role in maintaining the 
correct position for the exposed loop. It is possible that the 
position of this loop affects properties of the enzymes other 
than catalytic activity. If so, the conflicting values for zinc 
contents of short form enzymes that have previously been pub- 
lished [11,23-25] may reflect the possibility that enzyme may 
exist in two forms (either with or without he second zinc atom) 
which have indistinguishable kinetic characteristics. A more 
detailed physicochemical investigation may be required to elu- 
cidate the role of the second zinc atom in the short form en- 
zymes. 
The absence of the second zinc atom in the full-length en- 
zyme may be due to masking of the zinc binding site by the 
C-terminal domain during the folding process. As both the 
full-length and short forms of the enzymes are stable molecules, 
it seems possible that the role played by the second zinc atom 
in the truncated mutants is usually performed by the C-terminal 
domain in the full-length enzymes. It can be envisaged that in 
the full-length enzyme the loop that is exposed in the short 
forms could be held in place by binding to the C-terminal 
domain, thus eliminating the requirement for the second zinc 
atom. This may be a result of evolution from a simple single 
domain structure to a larger, more complex enzyme the activity 
of which can be highly regulated. The involvement of the resi- 
dues in the exposed loop in binding to the C-terminal domain 
could be tested using mutagenesis studies of full-length en- 
zymes. It would be interesting to know the zinc content of short 
forms of the matrix metalloproteinases which have been gener- 
ated autolytically by proteolysis [15], as these forms were orig- 
inally folded in the presence of the C-terminal domain. A crys- 
tallographic structure of a full-length matrix metalloproteinase 
should reveal whether the interactions involving the C-terminal 
domain predicted to mask the binding site of the second zinc 
atom do exist. 
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